Brief: Dawnrays Pharmaceutical Holdings Announces Framework Agreement For Acquisition Of Top Field
Feb 27 (Reuters) - Dawnrays Pharmaceutical Holdings Ltd
2348.HK :
* ANNOUNCES FRAMEWORK AGREEMENT FOR ACQUISITION OF TOP FIELD
LIMITED
* DEAL AT AN AGGREGATE CONSIDERATION OF HK$438 MILLION
* UNIT ENTERED INTO FRAMEWORK AGREEMENT TO BUY ENTIRE
ISSUED
SHARE CAPITAL OF TOP FIELD LTD FROM SUPPER FORT HOLDINGS
Source text for Eikon: ID:nHKS31kCth
Further company coverage: 2348.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO